chr3-38477296-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001106.4(ACVR2B):c.62G>A(p.Arg21His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R21C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001106.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACVR2B | NM_001106.4 | c.62G>A | p.Arg21His | missense_variant | 2/11 | ENST00000352511.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACVR2B | ENST00000352511.5 | c.62G>A | p.Arg21His | missense_variant | 2/11 | 1 | NM_001106.4 | P1 | |
ACVR2B | ENST00000461232.1 | n.3851G>A | non_coding_transcript_exon_variant | 1/10 | 1 | ||||
ACVR2B | ENST00000465020.5 | n.66G>A | non_coding_transcript_exon_variant | 2/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250970Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135674
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461800Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727204
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74344
ClinVar
Submissions by phenotype
Heterotaxy, visceral, 4, autosomal Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at